IOL Chemicals and Pharmaceuticals financials

·Pharma & HealthChart ›
Latest results Q1 FY27 · Apr–Jun 2026
Revenue
₹756cr+37.1% on Q1 FY26
Net profit
₹64.4cr+89.8% on Q1 FY26
EBITDA margin
13.7%+2.4 pts on Q1 FY26
EPS
₹2.20+89.7% on Q1 FY26

Quarterly results

Every quarter ›
₹ croreQ1 FY27Q1 FY26Change
Revenue756552+37.1%
EBITDA10362.1+66.5%
EBITDA margin13.7%11.3%+2.4 pts
Profit before tax86.745.5+90.5%
Net profit64.433.9+89.8%
EPS₹2.20₹1.16+89.7%

Over time

Q1 FY27 · Apr–Jun 2026latest
Revenue₹756 crNet profit₹64.4 crNet margin8.5%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12M
2,524
310
12.3%
229
168
6.7%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

IOLCP₹180.62

IOL Chemicals and Pharmaceuticals Limited

· Pharma & Health
₹ CrorePeersMOREPENLABFDCINNOVACAPORCHPHARMASENORESSANOFIGUJTHEMRPGLIFE
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
No consolidated annual data for IOLCP yet.

IOL Chemicals and Pharmaceuticals financials and key ratios

Prices at the 29 October 2026 close · figures from the company's filings with NSE

IOL Chemicals and Pharmaceuticals (NSE: IOLCP) had a market capitalisation of ₹5,429 crore at the 29 October 2026 close (₹184.93 a share), a PE ratio of 32.3 on the last four quarters' profit and a price-to-book ratio of 3.02. Its debt-to-equity ratio was 0.07 on 31 March 2026.

Share price used
₹184.93 · 29 October 2026 close
Latest balance sheet
31 March 2026

IOL Chemicals and Pharmaceuticals at a glance · consolidated

Market cap
₹5,429 Crat ₹184.93 · 29 Oct close
PE ratio (last 4 quarters)
32.3
Price to book (PB)
3.02book value ₹61.27 a share
Debt to equity
0.07net cash ₹69.9 Cr
Dividend yield
0.54%₹1 a share in 12 months
Net worth
₹1,799 Cr+6.6% vs 31 Mar 202531 March 2026

Questions

What is the IOL Chemicals and Pharmaceuticals PE ratio today?

IOL Chemicals and Pharmaceuticals' PE ratio is 32.3 at the 29 October 2026 close (₹184.93 a share): a market capitalisation of ₹5,429 crore divided by consolidated net profit of ₹168 crore over the last four quarters (Q2 FY26 to Q1 FY27).

Is IOL Chemicals and Pharmaceuticals debt free?

No. IOL Chemicals and Pharmaceuticals had borrowings of ₹132 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.07. Its cash and current investments were ₹202 crore, so it held net cash of ₹69.9 crore.

What is the IOL Chemicals and Pharmaceuticals book value per share?

IOL Chemicals and Pharmaceuticals' book value per share was ₹61.27 on 31 March 2026: shareholders' equity of ₹1,799 crore divided by the 29.36 crore shares in issue, up 6.6% from ₹57.49 a year earlier. The share price at the 29 October 2026 close was ₹184.93.

What is the IOL Chemicals and Pharmaceuticals PB ratio (price to book value)?

IOL Chemicals and Pharmaceuticals' price-to-book (PB) ratio is 3.02 at the 29 October 2026 close: a market capitalisation of ₹5,429 crore divided by shareholders' equity (book value) of ₹1,799 crore on 31 March 2026. That is a book value of ₹61.27 per share against a share price of ₹184.93.

What is the IOL Chemicals and Pharmaceuticals net worth?

IOL Chemicals and Pharmaceuticals' net worth — shareholders' equity in its consolidated balance sheet — was ₹1,799 crore on 31 March 2026, up 6.6% from ₹1,688 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹5,429 crore at the 29 October 2026 close.

What is the IOL Chemicals and Pharmaceuticals dividend yield?

IOL Chemicals and Pharmaceuticals' dividend yield is 0.54% at the 29 October 2026 close: dividends of ₹1 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹184.93. They were ₹1 on 17 February 2026 (interim).

What is the IOL Chemicals and Pharmaceuticals market cap?

IOL Chemicals and Pharmaceuticals' market capitalisation was ₹5,429 crore at the 29 October 2026 close: 29.36 crore shares at ₹184.93 each.

What is the IOL Chemicals and Pharmaceuticals debt to equity ratio?

IOL Chemicals and Pharmaceuticals' debt-to-equity ratio was 0.07 on 31 March 2026: borrowings of ₹132 crore against total equity of ₹1,799 crore. A year earlier, on 31 March 2025, it was 0.07.

What is the IOL Chemicals and Pharmaceuticals dividend in 2026 and its record date?

In 2026, IOL Chemicals and Pharmaceuticals has declared one dividend: ₹1 (interim) with record date 17 February 2026.

What are the IOL Chemicals and Pharmaceuticals latest quarterly results?

IOL Chemicals and Pharmaceuticals' latest results are for Q1 FY27 (April–June 2026), filed on 10 August 2026: consolidated net profit ₹64.4 crore, up 89.8% from ₹33.9 crore in Q1 FY26; revenue from operations ₹756 crore, up 37.1% year on year.

When are the IOL Chemicals and Pharmaceuticals next results?

IOL Chemicals and Pharmaceuticals will announce its Q2 FY27 results (July–September 2026) on Friday, 30 October 2026, the date of the board meeting it has notified to the exchanges.

Where do these IOL Chemicals and Pharmaceuticals figures come from?

From IOL Chemicals and Pharmaceuticals' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.